Pfizer launches mRNA flu vaccine trial
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.
Sep 28, 2021
0
295
US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza.
Jul 7, 2021
0
777
As we hopefully soon will start seeing the results of the efforts against COVID-19, we must simultaneously prepare for new and potentially more serious pandemics. Preventing new pandemics is definitely a common global challenge.
Apr 14, 2021
0
3
(HealthDay)—The recommended immunization schedule for adults has been updated for 2021, according to a report published online Feb. 11 in the Annals of Internal Medicine and in the Feb. 12 issue of the U.S. Centers for ...
Feb 12, 2021
0
2
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found. The ...
Dec 7, 2020
0
686
A protein produced by the human immune system can strongly inhibit corona viruses, including SARS-Cov-2, the pathogen causing COVID-19. An international team from Germany, Switzerland and the U.S. successfully showed that ...
Jul 28, 2020
0
275
Widespread use of pesticides and other agrochemicals can speed the transmission of the debilitating disease schistosomiasis, while also upsetting the ecological balances in aquatic environments that prevent infections, finds ...
Jul 17, 2020
0
399
Factors smaller than a cell and as large as the planet are at play when a virus leaps from an animal to a human.
Jul 9, 2020
0
0
A team of researchers from the University of Pennsylvania, the University of Pittsburgh, Centro Nacional de Diagnóstico y Referencia, Nicaragua, and the University of Michigan has found that the strains of influenza virus ...
The United States plans to give priority to the elderly, those with pre-existing conditions and essential workers once there is a vaccine against COVID-19, a senior Trump administration official said Tuesday.
Jun 16, 2020
0
11